Jazz Pharmaceuticals Plc (JAZZ)
231.39
-4.65
(-1.97%)
USD |
NASDAQ |
Oct 06, 16:00
231.62
+0.23
(+0.10%)
After-Hours: 20:00
Jazz Pharmaceuticals Profit Margin (Quarterly) : 15.96% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.96% |
| March 31, 2026 | 27.42% |
| December 31, 2025 | 16.98% |
| September 30, 2025 | 22.33% |
| June 30, 2025 | -68.71% |
| March 31, 2025 | -10.31% |
| December 31, 2024 | 17.56% |
| September 30, 2024 | 20.38% |
| June 30, 2024 | 16.46% |
| March 31, 2024 | -1.62% |
| December 31, 2023 | 9.30% |
| September 30, 2023 | 15.10% |
| June 30, 2023 | 10.91% |
| March 31, 2023 | 7.78% |
| December 31, 2022 | -24.76% |
| September 30, 2022 | -2.09% |
| June 30, 2022 | 3.72% |
| March 31, 2022 | 0.20% |
| December 31, 2021 | -3.94% |
| September 30, 2021 | -6.30% |
| June 30, 2021 | -48.33% |
| March 31, 2021 | 20.05% |
| December 31, 2020 | 20.05% |
| September 30, 2020 | 24.67% |
| June 30, 2020 | 20.41% |
| Date | Value |
|---|---|
| March 31, 2020 | -29.52% |
| December 31, 2019 | 12.72% |
| September 30, 2019 | 19.02% |
| June 30, 2019 | 49.03% |
| March 31, 2019 | 16.77% |
| December 31, 2018 | 33.47% |
| September 30, 2018 | 31.81% |
| June 30, 2018 | 18.45% |
| March 31, 2018 | 10.34% |
| December 31, 2017 | 53.21% |
| September 30, 2017 | 15.42% |
| June 30, 2017 | 26.78% |
| March 31, 2017 | 23.00% |
| December 31, 2016 | 29.42% |
| September 30, 2016 | 24.01% |
| June 30, 2016 | 30.04% |
| March 31, 2016 | 22.56% |
| December 31, 2015 | 24.28% |
| September 30, 2015 | 25.80% |
| June 30, 2015 | 26.40% |
| March 31, 2015 | 22.86% |
| December 31, 2014 | 24.87% |
| September 30, 2014 | 8.40% |
| June 30, 2014 | 14.97% |
| March 31, 2014 | -37.92% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| GH Research Plc | -- |
| Cosmo NV | -- |
| Axsome Therapeutics, Inc. | -23.50% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 22.06% |
| Return on Assets | 8.27% |
| Return on Invested Capital | 9.92% |
| Gross Profit Margin (Quarterly) | 76.30% |
| Operating Margin (Quarterly) | 26.91% |
| Return on Net Operating Assets | 11.90% |